ATE430164T1 - Hochaffine telomerase-t-zellen-rezeptoren - Google Patents

Hochaffine telomerase-t-zellen-rezeptoren

Info

Publication number
ATE430164T1
ATE430164T1 AT05718025T AT05718025T ATE430164T1 AT E430164 T1 ATE430164 T1 AT E430164T1 AT 05718025 T AT05718025 T AT 05718025T AT 05718025 T AT05718025 T AT 05718025T AT E430164 T1 ATE430164 T1 AT E430164T1
Authority
AT
Austria
Prior art keywords
cell receptors
telomerase
high affine
ilakflhwl
tcr
Prior art date
Application number
AT05718025T
Other languages
English (en)
Inventor
Bent Karsten Jakobsen
Yi Li
Original Assignee
Immunocore Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0411772A external-priority patent/GB0411772D0/en
Priority claimed from GB0419644A external-priority patent/GB0419644D0/en
Application filed by Immunocore Ltd filed Critical Immunocore Ltd
Application granted granted Critical
Publication of ATE430164T1 publication Critical patent/ATE430164T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
AT05718025T 2004-05-26 2005-03-15 Hochaffine telomerase-t-zellen-rezeptoren ATE430164T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0411772A GB0411772D0 (en) 2004-05-26 2004-05-26 High affinity telomerase t cell receptors
GB0419644A GB0419644D0 (en) 2004-09-03 2004-09-03 High affinity telomerase t cell receptors
PCT/GB2005/000970 WO2005116075A1 (en) 2004-05-26 2005-03-15 High affinity telomerase t cell receptors

Publications (1)

Publication Number Publication Date
ATE430164T1 true ATE430164T1 (de) 2009-05-15

Family

ID=34964746

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05718025T ATE430164T1 (de) 2004-05-26 2005-03-15 Hochaffine telomerase-t-zellen-rezeptoren

Country Status (7)

Country Link
US (1) US20100068186A1 (de)
EP (1) EP1758935B1 (de)
JP (1) JP5186209B2 (de)
AT (1) ATE430164T1 (de)
DE (1) DE602005014230D1 (de)
DK (1) DK1758935T3 (de)
WO (1) WO2005116075A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1812574A2 (de) * 2004-11-18 2007-08-01 Avidex Limited Lösliche bifunktionelle proteine
WO2006125962A2 (en) * 2005-05-25 2006-11-30 Medigene Limited T cell receptors which specifically bind to vygfvracl-hla-a24
GB0524477D0 (en) * 2005-11-30 2006-01-11 Avidex Ltd Isolated T cell receptors which specifically bind to vygfvracl-hla-24
WO2008037943A1 (en) * 2006-09-29 2008-04-03 Medigene Limited Cells transformed with nucleic acid encoding ny-eso t cell receptors
GB0816096D0 (en) * 2008-09-04 2008-10-15 Medigene Ltd Diabetes t cell receptors
HRP20171164T1 (hr) * 2010-09-20 2017-10-20 Biontech Cell & Gene Therapies Gmbh Antigen-specifični t stanični receptori i t stanični epitopi
AU2014301777B2 (en) * 2013-06-26 2017-03-30 Xlifesc, Ltd. High-stability T-cell receptor and preparation method and application thereof
NL2014935B1 (en) 2015-06-08 2017-02-03 Applied Immune Tech Ltd T cell receptor like antibodies having fine specificity.
WO2019069125A1 (en) 2017-10-06 2019-04-11 Oslo Universitetssykehus Hf CHIMERIC ANTIGEN RECEPTORS
US12331095B2 (en) * 2018-03-14 2025-06-17 Medigene Immunotherapies Gmbh Inducible T cell receptors and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL160359A0 (en) * 2001-08-31 2004-07-25 Avidex Ltd Soluble t cell receptor
AU2003216341A1 (en) * 2002-02-20 2003-09-09 Dyax Corporation Mhc-peptide complex binding ligands
PT1558643E (pt) * 2002-11-09 2009-08-24 Immunocore Ltd Apresentação de um receptor das células t
GB0400440D0 (en) * 2004-01-09 2004-02-11 Isis Innovation Receptor modulators

Also Published As

Publication number Publication date
DE602005014230D1 (de) 2009-06-10
WO2005116075A1 (en) 2005-12-08
JP2008510678A (ja) 2008-04-10
JP5186209B2 (ja) 2013-04-17
US20100068186A1 (en) 2010-03-18
EP1758935A1 (de) 2007-03-07
EP1758935B1 (de) 2009-04-29
DK1758935T3 (da) 2009-08-10

Similar Documents

Publication Publication Date Title
BRPI0511008A (pt) agentes de ligação de il-13
WO2006129085A3 (en) High affinity melan-a t cell receptors
HRP20240240T1 (hr) Protutijela anti-pd-l1 i njihova uporaba za poboljšanje funkcije t-stanice
HRP20130413A2 (hr) Taci-imunoglobulin fuzijski proteini
ATE388964T1 (de) Modifizierter löslicher t-zellen-rezeptor
HUE060029T2 (hu) Emberi antitestek, amelyek kötnek limfocita aktivációs gént-3 (LAG-3) és azok felhasználásai
SG196835A1 (en) Human anti-b7rp1 neutralizing antibodies
MA30153B1 (fr) Anticorps anti-ox40l et methodes correspondantes
CL2008000751A1 (es) Compuestos derivados de cicloprop[d]indolo[2,1-a][2]benzacepina sustituidos con heterociclos; composicion farmaceutica; y uso en el tratamiento de infeccion por hepatitis c.
TW200741277A (en) Holding device and exposure apparatus using the same
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
FR2913358B1 (fr) Dispositif d'allumage d'une composition aluminothermique, creuset l'incorporant et procedes associes.
MX348735B (es) Celulas madre mesenquimales que expresan los receptores tnf-alfa.
ATE430164T1 (de) Hochaffine telomerase-t-zellen-rezeptoren
TR201908551T4 (tr) Yakıt bileşimleri.
ATE517125T1 (de) ANTIKÖRPER GEGEN ßDEATH RECEPTOR 4ß (DR4) UND DEREN VERWENDUNGEN
MX2008001652A (es) Copolimeros de poliamonio-polisiloxano.
SG158060A1 (en) Compositions comprising an ultraviolet radiation-absorbing polymer
MX2008004734A (es) Composicion rica en leucina.
DK1809661T3 (da) Humant interferon-beta-mutein
EP1878809A4 (de) Verdrahtungsmaterial aus al-ni-b-legierung und elementstruktur damit
ZA200804197B (en) Pharmaceutical compositions comprising polymeric binders with non-hydrolysable covalent bonds and their use in treating celiac disease
TR199701092T1 (xx) Sukralfat içeren farmakotik kompozisyonlar.
CY1114497T1 (el) ΜΕΘΟΔΟΙ ΚΑΙ ΣΥΝΘΕΣΕΙΣ ΓΙΑ ΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΚΑΙ ΤΗΝ ΠΡΟΛΗΨΗ ΝΟΣΟΥ ΠΟΥ ΣΧΕΤΙΖΕΤΑΙ ΜΕ ΤΗΝ ΙΝΤΕΓΚΡΙΝΗ ανβ5
WO2006134190A3 (es) Agentes y métodos basados en el uso del dominio eda de la fibronectina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties